Felpreva 72.45 mg + 15.06 mg + 60.24 mg - Spot-on solution
Felpreva 72.45 mg + 15.06 mg + 60.24 mg - Spot-on solution
Authorised
- Tigolaner
- Emodepside
- Praziquantel
Product identification
Medicine name:
Felpreva 72.45 mg + 15.06 mg + 60.24 mg - Spot-on solution
Active substance:
- Tigolaner
- Emodepside
- Praziquantel
Target species:
-
Cat
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Tigolaner72.45/milligram(s)1.00Applicator
-
Emodepside15.06/milligram(s)1.00Applicator
-
Praziquantel60.24/milligram(s)1.00Applicator
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Available in:
-
Austria
-
Belgium
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Spot-on applicator with cap (PP), Package_size:1 spot-on applicator, Content:0.74 ml
- Packaging:Spot-on applicator with cap (PP), Package_size:20 spot-on applicators, Content:0.74 ml
- Packaging:Spot-on applicator with cap (PP), Package_size:10 spot-on applicators, Content:0.74 ml
- Packaging:Spot-on applicator with cap (PP), Package_size:2 spot-on applicators, Content:0.74 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol SA
Marketing authorisation date:
Manufacturing sites for batch release:
- VETOQUINOL BIOWET Sp. z o.o.
- Vetoquinol S.A.
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 27/01/2026
Bulgarian (PDF)
Published on: 27/01/2026
Croatian (PDF)
Published on: 27/01/2026
Czech (PDF)
Published on: 27/01/2026
Danish (PDF)
Published on: 27/01/2026
Dutch (PDF)
Published on: 27/01/2026
Estonian (PDF)
Published on: 27/01/2026
Finnish (PDF)
Published on: 27/01/2026
French (PDF)
Published on: 27/01/2026
German (PDF)
Published on: 27/01/2026
Greek (PDF)
Published on: 27/01/2026
Hungarian (PDF)
Published on: 27/01/2026
Icelandic (PDF)
Published on: 27/01/2026
Italian (PDF)
Published on: 27/01/2026
Latvian (PDF)
Published on: 27/01/2026
Lithuanian (PDF)
Published on: 27/01/2026
Maltese (PDF)
Published on: 27/01/2026
Norwegian (PDF)
Published on: 27/01/2026
Polish (PDF)
Published on: 27/01/2026
Portuguese (PDF)
Published on: 27/01/2026
Romanian (PDF)
Published on: 27/01/2026
Slovak (PDF)
Published on: 27/01/2026
Slovenian (PDF)
Published on: 27/01/2026
Spanish (PDF)
Published on: 27/01/2026
Swedish (PDF)
Published on: 27/01/2026
ema-puar-felpreva-v-5464-par-en.pdf
English (PDF)
Download Published on: 14/03/2023